Archive for the ‘Testing’ Category

Could Advanced Imaging Reveal Cognitive Impairment in Lyme Patients?

https://danielcameronmd.com/advanced-imaging-cognitive-impairment-lyme-patients/

COULD ADVANCED IMAGING REVEAL COGNITIVE IMPAIRMENT IN LYME PATIENTS?

Clinicians can now measure neurotransmitter levels in the brains of patients with mild cognitive impairment using magnetic resonance spectroscopy (MRS) with advanced 7 Tesla technology. MRS, also referred to as Nuclear Magnetic Resonance (NMR), shows the “levels of gamma-aminobutyric acid (GABA), glutathione and other neurotransmitters in brain regions of interest with greater precision than previous, lower-strength imaging systems,” explains Oeltzschner and colleagues. ¹

Multiple studies indicate that neurotransmitter levels can be “related to measures of behavioral outcomes, such as memory, reaction timing,” writes Oeltzschner in the journal Neurobiology of Aging.“These relationships can be region-specific.”

Measuring these levels, he adds, “could be a promising way to find out more about the inner workings of the disease and how it proceeds.”

Tognarelli agrees, writing, “Magnetic resonance spectroscopy (MRS) provides a non-invasive ‘window’ on biochemical processes within the body.”²

“The clinical use of in vivo magnetic resonance spectroscopy (MRS) has been limited for a long time, mainly due to its low sensitivity,” explains Marinette van der Graaf.³

“However,” she points out, “with the advent of clinical MR systems with higher magnetic field strengths such as 3 Tesla, the development of better coils, and the design of optimized radio-frequency pulses, sensitivity has been considerably improved.”

A study by Oeltzschner and colleagues looked at 13 people with mild cognitive impairment and found significant differences in several neurotransmitter levels relative to total creatine (tCr) when compared to healthy controls.

Results indicated patients with mild cognitive impairment had:

  • Decreased levels of g-aminobutyricacid (GABA);
  • Decreased levels of glutamate (Glu);
  • Decreased levels of N-acetylaspartate (NAA);
  • Increased levels of inosito (mI).

Oeltzschner from The Johns Hopkins University School of Medicine recommended additional studies “to improve the understanding of the regional specificity of brain metabolite changes and their effects on different domains of cognitive function.”

Editor’s Note: How about measuring the neurotransmitter levels in the brain of Lyme disease patients?
References:
  1. Oeltzschner, G. et al. Neurometabolites and associations with cognitive deficits in mild cognitive impairment: a magnetic resonance spectroscopy study at 7 Tesla. Neurobiol Aging. 2019 Jan;73:211-218.
  2. Joshua M. Tognarelli. Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians. J Clin Exp Hepatol. 2015 Dec; 5(4): 320–328.
  3. Marinette van der Graaf. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010 Mar; 39(4): 527–540.

 

 

 

 

Ticks Removed From Humans in Northwestern Italy – 30% Had Babesia

https://www.sciencedirect.com/science/article/pii/S2405939019301212

Survey on tick-borne pathogens in ticks removed from humans in Northwestern Italy

Highlights

Ticks have a considerable importance for public health.

Few data are present about ticks collected from humans.

128 ticks from 92 patients were analysed.

Almost 30% of the analysed tick pools were positive for Babesia spp.

The zoonotic species Babesia venatorum was the most prevalent species observed.

Abstract

Ticks are able to transmit several pathogens to the host while feeding, and thus are considered the most important vectors of infectious agents together with mosquitos. The global incidence of tick-borne diseases (TBDs) is rising, due to increased interactions between pathogens, hosts and vectors, linked to global changes. Given that information about the prevalence of tick-borne pathogens in ticks removed from humans in Italy are scarce, the aim of the present study was to identify the species of ticks biting humans in Northwestern Italy and tick-borne pathogens they harbour. An overall number of 128 ticks from 92 patients were collected from April to October 2018, almost 98% of which belonging to the Ixodes ricinus species. Molecular analysis showed the presence of Babesia spp. in 29 out of 93 analysed tick pools, with a Minimum Infection Rate (MIR) of 31.18% (29/93; CI95% 22.67–41.19%), while 1 out of 93 pools tested positive for SFG Rickettsiae (MIR = 1.08%; CI95% 0.19–5.84%). No samples tested positive for A. phagocytophilum and Borrelia spp. Sequencing revealed the presence of Babesia venatorum (28 pools), Theileria buffeli/orientalis complex (1 pool) and Rickettsia monacensis. Among these, B. venatorum and R. monacensis are zoonotic pathogens able to cause from moderate to severe infections in humans. These data highlight the importance of passive surveillance to assess the epidemiology of TBDs that pose a threat to human health.

__________________

**Comment**

Ixodes ricinus or the Castor Bean tick, sheep tick, or deer tick is considered a European hard-bodied tick; however, please note that migrating birds are transporting ticks all over the place.  https://madisonarealymesupportgroup.com/2019/03/09/danish-study-shows-migrating-birds-are-spreading-ticks-their-pathogens-including-places-without-sustainable-tick-populations/

https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/

https://madisonarealymesupportgroup.com/2019/07/28/coinfection-of-many-types-of-borrelia-rickettsia-babesia-bartonella-anaplasma-in-french-castor-bean-ticks/Excerpt:

It transmits numerous pathogens of medical and veterinary importance including Borrelia burgdorferi s.l. causing Lyme borreliosis, tick-borne encephalitis virus, Anaplasma phagocytophilum causing human granulocytic ehrlichiosis, Francisella tularensis causing Tularaemia, Rickettsia helvetica and Rickettsia monacensis, Babesia divergens and Babesia microti responsible for Babesiosis, Louping ill virus and Tribec virus.

The fact that 30% of ticks had Babesia should cause all doctors to pause and consider.

 

Treating Adrenal Dysfunction With Cortisol

https://www.holtorfmed.com/treating-adrenal-dysfunction-with-cortisol/?

Treating Adrenal Dysfunction with Cortisol

By Kent Holtorf, M.D. on Oct 17, 2019 

Originally Posted November 2012

Many people report feeling under constant pressure and stress which causes them to feel sluggish, irritable and fatigued. They are desperately trying to clear up that mental fogginess with coffee or other stimulants, just to crash worse afterwards. Does this sound like you?

Although it’s been widely accepted as the “common way of living in a working, modern society”, it is not normal.

Understanding Adrenal Fatigue

The adrenals are small glands that sit on the kidneys. They regulate many bodily processes through the production of hormones. The hormones produced by the adrenal glands help regulate blood sugar, immune function, and stress response. A disruption in the excretion of these hormones can lead to malfunction in these bodily processes and others.

Learn even more about the adrenals here.

Adrenal fatigue is a chronic condition wherein the adrenals are incapable of supplying the hormones needed for healthy bodily function. There are a number of potential causes for this dysfunction including physical trauma, a stressful professional or personal life, hormone imbalances, chronic illnesses, chronic infections, and sleep deficits. These and other physiological stressors trigger adrenal activity. If the adrenals continue to experience an increased demand, they will eventually become exhausted and incapable of sustaining healthy function.

Learn more about the causes of adrenal fatigue here.

The Symptoms of Adrenal Fatigue

Low levels of adrenal hormones, specifically cortisol, can result in symptoms such as:

  • Hypoglycemia
  • Fatigue
  • Muscle aches
  • Sugar or salt craving
  • Shakiness relieved with eating
  • Moodiness
  • Food sensitivities
  • Allergies
  • Recurrent infections
  • Dizzy when standing
  • Low blood pressure
  • Decreased ability to handle stress
  • “Brain fog”
  • Swollen ankles that are worse at night
  • Muscular weakness
  • Difficulty getting out of bed
  • Wiped out with exercise
  • Inability to tolerate thyroid replacement

Learn more about the symptoms of adrenal fatigue here.

The Role of Cortisol in Adrenal Function

The most important anti-stress hormone in the body is cortisol. It protects the body from excessive adrenal fatigue by:

  • normalizing blood sugar: cortisol increases the blood sugar level in the body, thus providing the energy needed for the body to physically escape threat or injury in order to survive. Cortisol works in tandem with insulin from the pancreas to provide adequate glucose for energy.
  • anti-inflammatory response: cortisol is a powerful anti-inflammatory agent. It is secreted as part of the anti-inflammatory response. Its objective is to remove and prevent swelling and redness of nearly all tissues.
  • immune system suppression: cortisol influences most cells that participate in the immune reaction, especially white blood cells. It suppresses white blood cells, natural killer cells, monocytes, macrophages and mast cells. It also suppresses adrenal fatigue.
  • vaso-constriction: people with low cortisol have low blood pressure and reduced activity to other body agents that constrict blood vessels.
  • physiology of stress: people with adrenal fatigue can not tolerate stress and will then succumb to severe stress. As their stress increases, progressively higher levels of cortisol are required. When the cortisol level cannot rise in response to stress, it is impossible to maintain the body in optimum stress response.

Cortisol sustains life via two opposite, but related, kinds of regulatory actions: releasing and activating the existing defense mechanisms of the body, while shutting down and modifying the same mechanisms to prevent them.

Using Cortisol to Safely and Effectively Treat Adrenal Fatigue

In the right situation and using the right dose, hormone replacement can be of great benefit for people with adrenal dysfunction. Medical science is just beginning to find out that a person can feel horrible and function poorly even with a minimal to moderate hormone deficiency that is clinically undetected by routine blood tests. This is evident in the case of adrenal fatigue.

Some physicians, notably Dr. Jefferies in the mid 1980s, have advocated low dose cortisol as safe for long-term use. Dr. Jefferies found that as long as the adrenal hormone level is kept within the normal range, the main toxicity that a patient might experience was a slight upset stomach, due to the body not being used to having the hormone come in through the stomach.

In an article published by Dr. Kent Holtorf in the Journal of Chronic Fatigue Syndrome about therapeutic doses of cortisol for patients with fibromyalgia and chronic fatigue syndrome, he states:

“Because treatment with low physiologic doses of cortisol (< 15 mg) has been shown to be safe and effective and routine dynamic ACTH testing does not appear to have significant diagnostic sensitivity, it is reasonable to give a therapeutic trial of physiologic doses of cortisol to the majority of patients with CFS and FM, especially to those who have symptoms that are consistent with adrenal dysfunction, have low blood pressure, or have baseline cortisol levels in the low or low-normal range. (…) Physiologic replacement of cortisol at doses of 5 mg to 15 mg a day are safe, with little or no associated risk. Such physiologic doses don’t carry the risk of adrenal and immune suppression or bone loss, which are well known risks of pharmacological doses of corticosteroids. Cortisol treatment carries significantly less risk and a greater potential for benefit than standard treatments, such as antidepressants, muscle relaxants, anticonvulsants and narcotics.”

Finding a Doctor that Understands Adrenal Fatigue

The adrenals are a critical component of healthy bodily function. Adrenal fatigue result in dramatic repercussions on your physical, emotional, and mental health. Treatment of adrenal fatigue should be tailored to you and your specific needs and can include low dose cortisol, adrenal glandulars, vitamin C, Pantothenic acid, licorice, and chromium.

At Holtorf Medical Group, our physicians are trained to provide you with cutting-edge testing and innovative treatments to find the answers you deserve and a treatment plan that is personalized to you. If you are experiencing symptoms of adrenal fatigue, give us a call at 877-508-1177 to see how we can help you!

Resources

1. Kent Holtorf, MD. “Diagnosis and Treatment of Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysfunction in Patients with Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM).” https://www.holtorfmed.com/download/chronic-fatigue-syndrome-and-fibromyalgia/Diagnosis_and_Treatment_of_HPA_Axis_Dysfunction.pdf

2. Kent Holtorf, MD. “Adrenal Fatigue Testing.” https://www.holtorfmed.com/download/other/Adrenal-Testing.pdf
3. Kent Holtorf, MD. “Adrenal Fatigue Treatment Options.” https://www.holtorfmed.com/download/other/Adrenal-Treatments.pdf.
4. William McK. Jefferies. “Safe Uses of Cortisol.” Book.

How the Adrenals and Thyroid Are Connected

By Holtorf Medical Group on Oct 15, 2019 11:40 am

Hormones are one of the most influential elements of wellness. These chemical structures relay messages throughout the body to regulate numerous functions. There are multiple systems responsible for production and regulation of hormones. Two of the most important being the adrenals and the thyroid. In addition to be essential for healthy bodily function, these two systems have a significant degree of influence on one another. Therefore, to better maintain wellness it is important to understand the role of the adrenals, the thyroid, and their mutual impact over each other.

What are the Adrenals?

The adrenals are small but highly influential organs located just above both kidneys. These are the glands responsible for controlling the body’s stress response as well as producing hormones essential for healthy bodily function. Some of the most notable adrenal hormones include pregnenolone, adrenaline, estrogen, progesterone, testosterone, DHEA, and cortisol – learn more about the adrenal hormones here. These and other adrenal hormones regulate areas such as metabolism, physical ability, libido, energy level, stress response, and much more.

Learn even more about the adrenal glands here.

What is the Thyroid?

The thyroid gland is located at the base of the neck. Like the adrenals, the thyroid regulates important areas of health including metabolism, mood, weight, neurological function, energy level, and more. The thyroid completes this complex task through the secretion of thyroid hormones. The most well-recognized thyroid hormones are thyroxine (T4) and triiodothyronine (T3). These hormones help to determine the activity level of virtually every cell and tissue in the body. It is for this reason that some refer to the thyroid as the body’s gas pedal.

Learn even more about the thyroid here.

Identifying Arenal and Thyroid Imbalances

Disruption of either the thyroid or the adrenals can result in a cascade of dysfunction throughout the body. There are several ways in which the adrenals and the thyroid may become dysfunctional including physical damage or trauma, chronic mental or physical stress, and chronic illness. These factors can contribute to hormonal imbalances that encourage the development of serious dysfunction such as adrenal fatigue and hypothyroidism.

Many symptoms of adrenal fatigue and hypothyroidism are shared. Because of this, it is common for patients to be misdiagnosed. Fatigue, poor sleep quality or insomnia, depression, PMS, brain fog, sensitivity to cold, weight gain, forgetfulness, and loss of libido are just some of the shared symptoms of adrenal dysfunction and hypothyroidism. If you experience some, or all, of these symptoms, it is important to assess both adrenal and thyroid function.

The Shared Influence of the Adrenals and the Thyroid

Although they are two different systems, the adrenals and the thyroid have a great deal of overlap. Typically, this is beneficial as both systems can support each other. However, because they are so closely related, if one system fails or malfunctions it often leads to disruption of the other.

The adrenal glands are responsible for regulating the body’s stress response. When we experience stress the adrenals release cortisol. The increase in cortisol triggers elevated immune activity, increased inflammatory response, heightened physical ability, and greater alertness. These are all beneficial qualities when handling stress in the short term. However, constant activation of the adrenals encourages further release of cortisol. Excess cortisol can negatively affect thyroid function and contribute to hypothyroidism. In part, this is why many individuals suffering from chronic stress also experience a decline in thyroid function.

For the thyroid to effectively regulate bodily function, T4 must be converted to T3 and interact with tissues throughout the body. Studies show that certain adrenal hormones play an important role in the conversion process of thyroid hormones. Additionally, some experts suggest that adrenal hormones are needed to effectively deliver T3 into cells and tissues. Therefore, poor adrenal function and a lack of adrenal hormones may inhibit thyroid activity resulting in symptoms of hypothyroidism.

Both systems play a significant role in maintaining healthy metabolic activity. If either system faulters, the other must work harder to make up the difference. For example, if metabolic activity is failing due to an underactive thyroid, the adrenals must work harder to maintain proper metabolic function. If thyroid function remains defunct, the adrenals will ultimately become exhausted resulting in adrenal fatigue. With these two systems exhausted, the body is almost certain to experience a significant and long-lasting decline in functionality.

The Importance of Treating Both Thyroid and Adrenal Dysfunction

Because hypothyroidism and adrenal fatigue both involve hormone deficiency, the conditions are treated in a similar fashion. The most common approach is to administer hormone therapy based on the individual needs of the patient. For example, if thyroid dysfunction is suspected, a patient may be given thyroid hormone supplements to increase their hormone values. Similarly, if adrenal signs point to adrenal fatigue, a doctor may recommend cortisol or other adrenal hormone supplements.

When treating the adrenals or the thyroid it is critical that diagnosis is accurate. For example, in the presence of adrenal malfunction, thyroid hormone therapies may actually cause greater disruption. This is because thyroid medication accelerates metabolic activity, which can place greater stress on the adrenals thereby contributing further to adrenal fatigue . Ideally, if a patient is presenting symptoms of either adrenal dysfunction or thyroid disease, both systems are evaluated, and a full gamut of tests are run to assess relevant hormone values.

Learn more about the importance of treating both thyroid and adrenal dysfunction here.

Finding a Doctor That Understands the Adrenal-Thyroid Connection

The body is composed of an intricate web of interlocking systems, many of which have direct influence on one other. An excellent example of this is the relationship between the adrenals and the thyroid. Both systems are integral to overall bodily function and exert their influence through the production of hormones. Due to their high degree of interconnectivity, dysfunction of one can have a dramatic negative impact on the other. Therefore, if symptoms of either adrenal or thyroid dysfunction develop, it is important to consider and assess both systems. Being aware of the close relationship between the adrenals and the thyroid and their important role in bodily function can help you better preserve their function and maintain greater wellness.

At Holtorf Medical Group, our physicians are knowledgeable in both thyroid and adrenal dysfunction, and how the two are connected. Because of this, they are able to provide you with cutting-edge testing and innovative treatments to find the answers you deserve and a treatment plan that is personalized to you. If you are experiencing symptoms of thyroid or adrenal dysfunction, give us a call at 877-508-1177!

References

1. Victor Parsons, DM and Ian Ramsay, MD. “Thyroid and adrenal relationships.” Postgrad. med. J. (May 1968) 44, 377-384.

2. Seck-Gassama et al. “Serum cortisol level variations in thyroid diseases.” Dakar Med. 2000;45(1):30-3.
3. Amy Myers, MD. “The Adrenal-Thyroid Connection.” Amy Myers.

_____________________

For more:  https://madisonarealymesupportgroup.com/2019/10/26/5-thyroid-lies-your-endocrinologist-may-try-to-tell-you/

https://madisonarealymesupportgroup.com/2019/11/12/is-it-mental-illness-or-hashimotos-thyroiditis/

 

 

 

 

NY Grants Approval for IGeneX’s Newly Developed Tick-Borne Relapsing Fever ImmunoBlot Tests

https://www.prnewswire.com/news-releases/new-york-state-grants-approval-for-igenexs-newly-developed-tick-borne-relapsing-fever-tbrf-immunoblot-tests-300933720.html

New York State Grants Approval for IGeneX’s Newly Developed Tick-Borne Relapsing Fever (TBRF) ImmunoBlot Tests

TBRF ImmunoBlots (IgM and IgG) represent a quantum leap in testing for tick-borne diseases, particularly for patients with Lyme-like symptoms

NEWS PROVIDED BY

IGeneX


MILPITAS, Calif., Oct. 8, 2019 /PRNewswire/ — The Division of Laboratories of the Department of Health of the State of New York has approved IGeneX’s newly developed Tick-Borne Relapsing Fever (TBRF) ImmunoBlots (IgM and IgG), making them immediately available to New Yorkpractitioners.

Until recently, diagnostic tests for TBRF have been grossly insensitive and have not been able to detect many of the ever-growing list of species and strains of TBRF Borrelia carried by hard and soft ticks. The new IGeneX ImmunoBlots overcome these obstacles with the ability to detect antibodies to TBRF Borrelia species including, but not limited to, B. hermsii, B. miyamotoi, and B. turicatae.

TBRF is often considered a Lyme disease imitator because both TBRF and Lyme sufferers display many similar symptoms, such as high fever, chills, and headache, often leading to misdiagnosis. Moreover, some of the Borrelia that cause TBRF are transmitted by the same ticks that transmit B. burgdorferi, the causative agent of Lyme disease. Therefore, it is important for physicians to test for both TBRF and Lyme.

“We are very excited to be able to offer the TBRF ImmunoBlots to physicians in New York State,” said Dr. Jyotsna Shah, President of IGeneX. “Doctors use to call me and say ‘my patients have Lyme-like symptoms. Why are your tests negative?’ We now know that their symptoms might have been due to TBRF Borrelia infection. These new TBRF ImmunoBlot tests will help patients in this group, as well as patients with Lyme and TBRF Borrelia mixed infections.”

The accuracy of the TBRF ImmunoBlot has been established. The specificity is 98.5% for IgM and IgG based on a study performed on 212 well characterized samples, of which 50 were provided by the CDC. Additionally, the TBRF ImmunoBlots can detect the full spectrum of disease: early, active and late-stage disease.

For more information on IGeneX and the TBRF ImmunoBlot tests, please visit http://igenex.com.

About IGeneX
For over 25 years, IGeneX has been at the forefront of research and development of diagnostic testing for Lyme disease, TBRF, Bartonella, and other tick-borne diseases. IGeneX arms its talented scientists with the most cutting-edge technology available to enable them to find new solutions that challenge the status quo of testing for Lyme and associated tick-borne diseases. The mission of IGeneX is to aid practitioners in their diagnosis of tick-borne illnesses by providing the most comprehensive testing possible. Learn more at: www.igenex.com

Media Contact:
Joseph Sullivan
225913@email4pr.com 
408-504-7691

SOURCE IGeneX

Related Links

http://www.igenex.com

___________________

More on Relapsing Fever:  https://madisonarealymesupportgroup.com/2018/12/28/relapsing-fever-spirochete-uniquely-adapted-to-highly-oxidative-salivary-glands-of-soft-bodied-tick/

https://madisonarealymesupportgroup.com/2019/03/22/tick-borne-relapsing-fever-in-arizona/

https://madisonarealymesupportgroup.com/2017/12/22/tbrf-in-texan-dogs-yep-despite-poor-tests-its-there/

https://madisonarealymesupportgroup.com/2019/01/10/relapsing-fever-found-at-popular-recreation-site-in-ca-ticks/

https://madisonarealymesupportgroup.com/2018/12/20/tick-borne-relapsing-fever-as-a-potential-veterinary-medical-problem/

https://madisonarealymesupportgroup.com/2017/05/04/us-soldier-aquires-tickborne-relapsing-fever-caused-by-b-turicatae-from-a-ornithodoros-turicata-tick/

https://madisonarealymesupportgroup.com/2019/03/17/first-case-of-b-corocidurae-in-native-european-presenting-as-meningitis-with-cranial-polyneuritis-cavernous-sinus-thrombosis/

FDA Approves Cobas Babesia Test for Individual Blood Donation Testing

https://www.roche.com/media/releases/med-cor-2019-09-20.htm

Media Release

Basel, 20 September 2019

FDA approves cobas Babesia, Roche’s first whole blood test for donor screening

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for the cobas Babesia test for use on the cobas 6800/8800 Systems for individual blood donation testing. This is Roche’s first commercially available whole blood test to screen donations and follows May 2019 FDA-updated industry guidance recommending screening and testing for Babesia, to reduce the risk of transmitting the parasite through transfusions.1

cobas Babesia detects parasites that live in red blood cells. This test is an important advancement because the Babesia parasite cannot be detected in traditional plasma or serum samples. The test is able to detect the four common species of Babesia and employs the new whole blood collection tube, which simplifies Babesia sample preparation by consolidating steps within the tube itself to provide an efficient solution for testing laboratories.

In most cases, the Babesia parasite is transmitted to humans through the bite of an infected tick; however, the parasite can also be transmitted through blood transfusions or from mother to foetus during pregnancy. The parasite infects and destroys red blood cells which can lead to anaemia and related life-threatening complications, particularly in the elderly or otherwise immunocompromised patients. In healthy people, the infection can be asymptomatic, or cause a range of mild flu-like symptoms.

“We are dedicated to helping save patients’ lives by providing advanced solutions to enable the protection of the global blood supply from infectious diseases. With the approval of Roche’s first whole blood test used in blood screening we can help healthcare professionals further diminish potential risks of infection from transfused blood products,” said Thomas Schinecker, CEO Roche Diagnostics. “In addition, we hope to help customers improve their lab efficiency by simplifying sample prep while ensuring maximum detection of infectious pathogens in the blood and the safety of the blood supply for the patients we serve.”

The Roche Blood Safety Solutions offering now provides the most comprehensive testing solution for blood donor screening utilising the fully automated cobas 6800/8800 System. This novel test approval follows the successful launch of the cobas Zika test, which was the first Zika test available for donor screening in the U.S. This new Babesia test expands the menu of tests available for the cobas 6800/8800 Systems for use in U.S. donor screening laboratories. This menu includes cobas MPX, cobas WNV and cobas Zika. In addition, the menu includes cobas DPX2, which is used in testing labs that support plasma fractionators.

About the cobas Babesia test for use on the cobas 6800/8800 Systems

The cobas Babesia test for use on the cobas 6800/8800 Systems is a qualitative in vitro nucleic acid screening test for the direct detection of Babesia DNA and RNA in whole blood specimens from individual human blood donors. It detects the four species of Babesia known to cause disease in humans and can be performed with the other routine blood donor screening tests.

The fully automated cobas 6800/8800 Systems offer the fastest time to results with the highest throughput and the longest walk-away time available among automated molecular platforms, providing donor screening laboratories with improved operating efficiency and the flexibility to adapt to changing testing demands. The cobas Babesia test is the latest addition to Roche’s assay menu for donor screening laboratories — which includes cobas MPX, cobas DPX, cobas HEV, cobas WNV, cobas CHIKV/DENV and cobas Zika (US-IVD) — all of which are run on the cobas 6800/8800 Systems. Not all assays are available in all markets.

Since 2014, the cobas 6800 and cobas 8800 Systems have established the new standard for routine molecular testing by delivering fully integrated, automated solutions that serve the areas of donor screening, infectious disease, sexual health, transplant, respiratory and antimicrobial stewardship.

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2018 employed about 94,000 people worldwide. In 2018, Roche invested CHF 11 billion in R&D and posted sales of CHF 56.8 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

All trademarks used or mentioned in this release are protected by law.

__________________

For more:  https://madisonarealymesupportgroup.com/category/babesia-treatment/

https://madisonarealymesupportgroup.com/2019/09/05/babesia-subverts-adaptive-immunity-and-enhances-lyme-disease-severity/

https://madisonarealymesupportgroup.com/2019/08/25/babesia-microti-borrelia-burgdorferi-coinfection/

https://madisonarealymesupportgroup.com/2018/10/11/babesia-found-in-patient-with-persistent-symptoms-following-lyme-treatment/

While a current article downplays Babesia in Canada, another article shows it’s much more of a problem than suspected:  https://madisonarealymesupportgroup.com/2019/08/21/prevalence-of-babesia-in-canadian-blood-donors-june-october-2018/

https://madisonarealymesupportgroup.com/2019/07/11/characteristics-of-transfusion-transmitted-babesia-microti-american-red-cross-2010-2017/  This clearly shows there were more than 200 Babesia transfusion-transmissions reported. It also shows you don’t have to reside in an endemic area or travel to an endemic area to get it. The article also clearly points out that the geographic range of ticks is expanding, which means the pathogens they carry will as well.